Kincell Bio is a quality-led CDMO and technology solutions provider accelerating the development and manufacturing of immune cell therapies. With deep expertise in autologous and allogeneic modalities, we support programs from early development through commercial launch. Our integrated analytical, process development, and GMP manufacturing capabilities, along with purpose-built U.S. facilities, deliver scalable, cost-effective, and regulatory-ready solutions tailored to your program.